These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of the effectiveness of radioactive phosphorus and chlorambucil in patients with chronic lymphocytic leukemia. SPRAGUE CC Cancer Chemother Rep; 1962 Feb; 16():235-40. PubMed ID: 13915911 [No Abstract] [Full Text] [Related]
3. Comparison of CB-1348 (chlorambucil, leukeran) and CB-1364. RUNDLES W; GRIZZLE J; BONO VH; JONSSON U; HUGULEY CM; CORLEY CC Cancer Chemother Rep; 1962 Feb; 16():223-30. PubMed ID: 14495284 [No Abstract] [Full Text] [Related]
4. The use of chlorambucil and steroids in the treatment of chronic lymphocytic leukaemia. GALTON DA; WILTSHAW E; SZUR L; DACIE JV Br J Haematol; 1961 Jan; 7():73-98. PubMed ID: 13703205 [No Abstract] [Full Text] [Related]
5. Treatment of malignant lymphomas and lymphadenoses with leukeran. LIBANSKY J; CHUDOMEL V; BRABEC V; SOCHMAN J Neoplasma; 1959; 6():415-24. PubMed ID: 14416684 [No Abstract] [Full Text] [Related]
6. Chlorambucil in treatment of chronic lymphocytic leukemia and certain lymphomas. GELLHORN A; HYMAN GA; ULTMANN JE J Am Med Assoc; 1956 Sep; 162(3):178-83. PubMed ID: 13357311 [No Abstract] [Full Text] [Related]
7. Effect of uracil mustard in malignant lymphoma and chronic lymphatic leukemia. THEOLOGIDES A; KENNEDY BJ Minn Med; 1962 Feb; 45():165-8. PubMed ID: 13920550 [No Abstract] [Full Text] [Related]
8. [Observations on the application of CB-1348 in lymphatic leukemias]. LAWKOWICZ W; BECALSKI J Pol Arch Med Wewn; 1959; 29(3):420-2. PubMed ID: 13667708 [No Abstract] [Full Text] [Related]
9. Clinical evaluation of the effect of degranol. SANDOR L; CERNY V; UJHAZY V; WINKLER A Neoplasma; 1959; 6():179-82. PubMed ID: 14441442 [No Abstract] [Full Text] [Related]
10. Early experience with p-(N, N-di-2-chloroethyl)-aminophenylbutyric acid (CB 1348), a new chemotherapeutic agent effective in the treatment of chronic lymphocytic leukemia. ALTMAN SJ; HAUT A; CARTWRIGHT GE; WINTROBE MM Cancer; 1956; 9(3):512-7. PubMed ID: 13330000 [No Abstract] [Full Text] [Related]
11. Clinical experience with CB 1348 (NN-di(2-chloroethyl, -P-aminophenylbutyric acid) in the treatment of chronic lymphatic leukaemia. HANSEN PB Acta Radiol (Stockh); 1957 Mar; 47(3):210-16. PubMed ID: 13424344 [No Abstract] [Full Text] [Related]
15. [Case of lymphatic leukemia with unusual skin manifestations]. BOKONJIC N Med Arh; 1952; 6(4):89-97. PubMed ID: 13024536 [No Abstract] [Full Text] [Related]
16. The clinical use of chlorambucil: a critical study. MILLER DG; DIAMOND HD; CRAVER LF N Engl J Med; 1959 Sep; 261():525-35. PubMed ID: 14422485 [No Abstract] [Full Text] [Related]
17. [Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma]. KLIMA R; HORNISCHER R Wien Med Wochenschr; 1953 Jan; 103(1):11-4. PubMed ID: 13049846 [No Abstract] [Full Text] [Related]
18. Combination therapy with cobalt-60 and chlorambucil in the treatment of disseminated ovarian carcinomatosis. MILLER SP; BRENNER SM Cancer Chemother Rep; 1962 Feb; 16():455-62. PubMed ID: 14474106 [No Abstract] [Full Text] [Related]
19. Chlorambucil in childhood cancer. PINKEL D Cancer; 1961; 14():36-41. PubMed ID: 13735856 [No Abstract] [Full Text] [Related]
20. [Treatment of erythroderma with leukeran]. LIBANSKY J; TRAPL J Cas Lek Cesk; 1960 Nov; 99():1447-50. PubMed ID: 13761863 [No Abstract] [Full Text] [Related] [Next] [New Search]